Proximal Tubule Cell Compartments and Transport Direction

Why the Proximal-Tubule Cell Needs Its Own Compartment

A drug can cross the proximal-tubule epithelium by interacting with two distinct cell surfaces. The basolateral membrane faces the renal interstitium and peritubular blood; the apical membrane faces the tubular lumen. A model that represents only blood and lumen can describe a net transfer between them, but it cannot show the concentration inside the intervening cell or distinguish what crosses each membrane.

For a cell-mediated route, blood-to-lumen movement consists of two separate steps: drug crosses from the blood-facing side into the cell, then crosses from the cell into the lumen. These steps need not have the same rate, direction, or driving force. The earlier material on tubular secretion as a two-membrane flux introduced this sequential structure; here the emphasis is on defining the compartments and reading the direction of each membrane crossing.

In a PBPK model, each compartment has a drug amount and a concentration. For transporter direction and passive chemical driving forces, the relevant concentration is generally the unbound concentration, denoted here by \(C_{B,u}\), \(C_{C,u}\), and \(C_{L,u}\). The amount in a compartment is not interchangeable with its concentration: for a given amount, a smaller compartment can have a higher concentration. Binding within the cell can also make total cellular amount a poor indicator of the concentration available to cross a membrane.

Membrane Orientation and Signed Fluxes

A sign convention makes verbal descriptions and model equations agree. Define \(J_{BC}\) as the signed flux across the basolateral membrane, positive from blood to cell. Define \(J_{CL}\) as the signed flux across the apical membrane, positive from cell to lumen. A positive \(J_{BC}\) is basolateral uptake into the cell; a negative \(J_{BC}\) is basolateral efflux from the cell toward blood. A positive \(J_{CL}\) is apical efflux from the cell into lumen; a negative \(J_{CL}\) is apical uptake from lumen into the cell.

The sign convention is about direction across a named membrane. “Uptake” is therefore incomplete unless the receiving cell and membrane are clear: uptake from blood across the basolateral membrane and uptake from lumen across the apical membrane are both into the cell, but they start in different compartments. Similarly, efflux can be toward either blood or lumen.

For a simple passive, linear-permeability description, define each concentration difference as donor minus acceptor in the chosen positive direction. If the permeabilities are \(PS_{BC}\) and \(PS_{CL}\), respectively, the signed passive fluxes are:

Here \(PS\) has units of volume per time, so multiplying it by concentration gives amount per time. Under this idealized passive model, a positive difference favors movement in the defined positive direction, and a negative difference favors the reverse direction. This conclusion assumes the stated linear relationship is appropriate and that the concentration difference captures the relevant driving force. For charged compounds or other cases in which electrical or chemical coupling matters, a concentration difference alone may not describe the full driving force.

Cell Mass Balance Links the Two Membranes

Let \(A_C\) be the drug amount in the cell compartment. With the sign convention above, basolateral flux adds drug to the cell when positive, while apical flux removes drug from the cell when positive. If \(R_C\) is the net rate of intracellular loss through metabolism or another explicitly represented process (positive for loss), conservation of mass gives:

This equation is a bookkeeping identity once all fluxes and processes affecting the cell are included. It does not prescribe a particular transporter mechanism. If there is no metabolism or other cellular source or sink, \(R_C=0\). At steady state, \(dA_C/dt=0\), so the net basolateral input equals the net apical output when those are the only two routes. This equality concerns signed net fluxes; it does not mean the two membranes have identical transport capacity or that every molecule crossing one membrane immediately crosses the other.

If a cell concentration is calculated from amount and a fixed compartment volume \(V_C\), then \(C_C=A_C/V_C\) for that stated concentration definition, and \(dC_C/dt=(1/V_C)dA_C/dt\). In a detailed model with intracellular binding, the relation between total amount and unbound concentration must be specified separately. A mass balance on total amount should not silently be treated as an equation for unbound concentration.

Choosing a Representation and Checking Its Direction

The three-compartment representation is useful when the model question concerns intracellular exposure, membrane-specific transport, or the sequential steps linking blood and lumen. A simpler two-compartment blood-to-lumen representation may be adequate when only net transfer is needed and cell concentration is not an output of interest. The simpler representation has fewer states and parameters, but it cannot diagnose whether a change arises at the basolateral or apical crossing. Conversely, adding a cell compartment without data or a clear mechanistic purpose can introduce parameters that are difficult to constrain.

Several checks help catch direction and bookkeeping errors before interpreting a simulated profile:

• Draw the membrane orientation. Place blood or interstitium outside the basolateral surface, the cell between the surfaces, and lumen beyond the apical surface.
• Write the positive direction on every flux. Do not use “influx” or “efflux” without naming the cell and membrane reference.
• Check gradient subtraction order. For the convention here, basolateral passive flux uses \(C_{B,u}-C_{C,u}\); apical passive flux uses \(C_{C,u}-C_{L,u}\). Reversing the subtraction without also reversing the sign convention reverses the predicted direction.
• Check amount conservation. A positive basolateral flux must add to the cell balance, while a positive apical flux must subtract from it. Amount leaving one compartment should enter another unless a separately represented process removes it.
• Check the concentration definition. Total cell amount, total concentration, and unbound concentration are not automatically the same quantity.

A common mistake is to reason, “The lumen concentration is lower than the cell concentration, so every apical transporter must carry drug into the lumen.” The gradient supports that direction only for the stated passive model. A transporter flux may have a different direction, and the net flux is determined by the combined contributions. The correction is to identify the membrane, define the signed crossing, calculate the passive contribution under its assumptions, and represent any transporter contribution separately.

The model also has limits. Treating blood, cell, and lumen as well-mixed compartments averages spatial variation and may be unsuitable when concentration changes along the tubule are important. A linear passive \(PS\) relation is an assumption, not a universal law. Finally, a blood-to-lumen cell route is not the only way drug can reach urine: glomerular filtration is a separate route that bypasses the epithelial cell. Keeping that route distinct prevents a modeled cellular flux from being mistaken for total renal delivery to urine.